Smart mesoporous silica nanoparticles for controlled-release drug delivery

Nanotechnology Reviews

Volumn 5, Issue 2, 2016, Pages 195-207

  Karimi, Mahdi ^a   Mirshekari, Hamed ^a   Aliakbari, Masoumeh ^b   Sahandi Zangabad, Parham ^c   Hamblin, Michael R ^d,e,f  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHARIF UNIVERSITY OF TECHNOLOGY   (Iran)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

drug delivery systems; enzyme; light responsive nanocarriers; magnetic; mesoporous silica nanoparticles; pH; redox; stimuli responsive; temperature

Indexed keywords

CONTROLLED DRUG DELIVERY; DRUG INTERACTIONS; ENZYMES; MAGNETIC LEVITATION VEHICLES; MESOPOROUS MATERIALS; NANOMAGNETICS; PH; SILICA NANOPARTICLES; TEMPERATURE;

DRUG DELIVERY SYSTEM; MAGNETIC; MESOPOROUS SILICA NANOPARTICLES; NANO-CARRIERS; REDOX; STIMULI-RESPONSIVE;

TARGETED DRUG DELIVERY;

EID: 84964570416     PISSN: 21919089     EISSN: 21919097     Source Type: Journal    
DOI: 10.1515/ntrev-2015-0057     Document Type: Review

References (86)

1. Fleige E, Quadir MA, Haag R. Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. Adv. Drug Deliv. Rev. 2012, 64, 866-884.
2. Vallet-Regi M, Rámila A, Del Real RP, Pérez-Pariente J. A new property of MCM-41: drug delivery system. Chem. Mater. 2001, 13, 308-311.
3. Yang P, Gai S, Lin J. Functionalized mesoporous silica materials for controlled drug delivery. Chem. Soc. Rev. 2012, 41, 3679.
4. Shchipunov YA, Burtseva YV, Karpenko TY, Shevchenko NM, Zvyagintseva TN. Highly efficient immobilization of endo-1, 3--d-glucanases (laminarinases) from marine mollusks in novel hybrid polysaccharide-silica nanocomposites with regulated composition. J. Mol. Catal. B Enzym. 2006, 40, 16-23.
5. Bao G, Mitragotri S, Tong S. Multifunctional nanoparticles for drug delivery and molecular imaging. Annu. Rev. Biomed. Eng. 2013, 15, 253-282.
6. Argyo C, Weiss V, Bräuchle C, Bein T. Multifunctional mesoporous silica nanoparticles as a universal platform for drug delivery. Chem. Mater. 2014, 26, 435-451.
7. He Q, Shi J. Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility. J. Mater. Chem. 2011, 21, 5845.
8. Li Z, Barnes JC, Bosoy A, Stoddart JF, Zink JI. Mesoporous silica nanoparticles in biomedical applications. Chem. Soc. Rev. 2012, 41, 2590.
9. Tang F, Li L, Chen D. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Adv. Mater. 2012, 24, 1504-1534.
10. Shchipunov YA, Kojima A, Imae T. Polysaccharides as a template for silicate generated by sol-gel processes. J. Colloid Interface Sci. 2005, 285, 574-580.
11. Yokoi T, Kubota Y, Tatsumi T. Amino-functionalized mesoporous silica as base catalyst and adsorbent. Appl. Catal. A Gen. 2012, 421: 14-37.
12. Slowing II, Vivero-Escoto JL, Trewyn BG, Lin VS-Y. Mesoporous silica nanoparticles: structural design and applications. J. Mater. Chem. 2010, 20, 7924.
13. Brook M a, Chen Y, Guo K, Zhang Z, Jin W, Deisingh A, Cruz-Aguado J, Brennam JD. Proteins entrapped in silica monoliths prepared from glyceroxysilanes. J. Sol-Gel Sci. Technol. 2004, 31, 343-348.
14. Choy JH, Oh JM, Choi SJ. Bio-Inorganic conjugates for drug and gene delivery. In Bio-inorganic Hybrid Nanomaterials: Strategies, Syntheses, Characterization and Applications. Wiley-VCH Verlag GmbH & Co. John Wiley & Sons: Germany. 2008, pp. 401-18.
15. Shchipunov YA, Krekoten A V. Hybrid organic - inorganic nanocomposites fabricated with a novel biocompatible precursor using sol-gel processing. Compos. Interfaces. 2005, 11, 587-607.
16. Halamová D, Zelenák V. NSAID naproxen in mesoporous matrix MCM-41: drug uptake and release properties. J. Incl. Phenom. Macrocycl. Chem. 2012, 72, 15-23.
17. Halamová D, Badanicová M, Zelenák V, Gondová T, Vainio U. Naproxen drug delivery using periodic mesoporous silica SBA-15. Appl. Surf. Sci. 2010, 256, 6489-6494.
18. Chen Y, Chen H, Ma M, Chen F, Limin G, Zhang L, Shi J. Double mesoporous silica shelled spherical/ellipsoidal nanostructures: synthesis and hydrophilic/hydrophobic anticancer drug delivery. J. Mater. Chem. 2011, 21, 5290.
19. Lang N, Tuel A. A fast and efficient ion-exchange procedure to remove surfactant molecules from MCM-41 materials. Chem. Mater. 2004, 16, 1961-1966.
20. Karimi M, Solati N, Amiri M, Mirshekarid H, Mohamedb E, Taherib M, Hashemkhanib M, Saeidib A, Estiare MA, Kianib P, Ghasemic A, Basrif SMM, Arefe AR, Hamblin MR. Carbon nanotubes part I: preparation of a novel and versatile drug-delivery vehicle. Expert Opin. Drug Deliv. 2015, 12, 1-17.
21. Mamaeva V, Sahlgren C, Lindén M. Mesoporous silica nanoparticles in medicine - Recent advances. Adv. Drug Deliv. Rev. 2013, 65, 689-702.
22. Rosenholm JM, Sahlgren C, Linden M. Multifunctional mesoporous silica nanoparticles for combined therapeutic, diagnostic and targeted action in cancer treatment. Curr. Drug Targets. 2011, 12, 1166-1186.
23. Kratz F, Müller IA, Ryppa C, Warnecke A. Prodrug strategies in anticancer chemotherapy. ChemMedChem. 2008, 3, 20-53.
24. Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VS-Y. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small. 2010, 6, 1952-1967.
25. Slowing II, Vivero-Escoto JL, Wu C-W, Lin VS-Y. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv. Drug Deliv. Rev. 2008, 60, 1278-1288.
26. Duncan R. The dawning era of polymer therapeutics. Nat. Rev. Drug Discov. 2003, 2, 347-360.
27. Pal N, Bhaumik A. Soft templating strategies for the synthesis of mesoporous materials: inorganic, organic-inorganic hybrid and purely organic solids. Adv. Colloid Interface Sci. 2013, 189-190, 21-41.
28. Wang Y, Gu H. Core-shell-Type magnetic mesoporous silica nanocomposites for bioimaging and therapeutic agent delivery. Adv. Mater. 2015, 27, 576-585.
29. Dou B, Hu Q, Li J, Qiao S, Hao Z. Adsorption performance of VOCs in ordered mesoporous silicas with different pore structures and surface chemistry. J. Hazard Mater. 2011, 186, 1615-1624.
30. Manzano M, Vallet-Regí M. New developments in ordered mesoporous materials for drug delivery. J. Mater. Chem. 2010, 20, 5593.
31. Mofazzal Jahromi MA, Karimi M, Azadmanesh K, Naderi Manesh H, Hassan ZM, Moazzeni SM. The effect of chitosan-Tripolyphosphate nanoparticles on maturation and function of dendritic cells. Comp. Clin. Path. 2013, 1-7 doi:10.1007/s00580-013-1799-0.
32. Rahman IA, Padavettan V. Synthesis of silica nanoparticles by sol-gel: size-dependent properties, surface modification, and applications in silica-polymer nanocompositesa review. J. Nanomater. 2012, 2012. doi:10.1155/2012/132424.
33. Karimi M, Solati N, Ghasemi A, Estiard MA, Hashemkhanib M, Kianib P, Mohamedb E, Saeidib A, Taherib M, Avcief P, Arefgh AR, Amiric M, Baniasadic F, Hamblin MR. Carbon nanotubes part II: a remarkable carrier for drug and gene delivery. Expert Opin. Drug Deliv. 2015, 12, 1-17.
34. Chan M-H, Lin H-M. Preparation and identification of multifunctional mesoporous silica nanoparticles for in vitro and in vivo dual-mode imaging, theranostics, and targeted tracking. Biomaterials. 2015, 46, 149-158.
35. Sun Y-L, Zhou Y, Li Q-L, Yang Y-W. Enzyme-responsive supramolecular nanovalves crafted by mesoporous silica nanoparticles and choline-sulfonatocalix[4]arene [2]pseudorotaxanes for controlled cargo release. Chem. Commun. 2013, 49, 9033.
36. Yang Q, Wang S, Fan P, Wang L, Di Y, Lin K, Xiao F-S. pHresponsive carrier system based on carboxylic acid modified mesoporous silica and polyelectrolyte for drug delivery. Chem. Mater. 2005, 17, 5999-6003.
37. Lu J, Choi E, Tamanoi F, Zink JI. Light-Activated nanoimpellercontrolled drug release in cancer cells. Small. 2008, 4, 421-426.
38. Sirsi SR, Borden MA. State-of-The-Art materials for ultrasoundtriggered drug delivery. Adv. Drug Deliv. Rev. 2014, 72, 3-14.
39. Cohen Y, Shoushan SY. Magnetic nanoparticles-based diagnostics and theranostics. Curr. Opin. Biotechnol. 2013, 24, 672-681.
40. Zhang Z, Liu C, Bai J, Wu C, Xiao Y, Li Y, Zheng J, Yang R, Tan W. Silver nanoparticle gated, mesoporous silica coated gold nanorods (AuNR@MS@AgNPs): low premature release and multifunctional cancer theranostic platform. ACS Appl. Mater. Interfaces. 2015, 1-34. doi:10.1021/acsami.5b00368.
41. Wang Y, Han N, Zhao Q, Bai L, Li J, Jiang T, Wang S. Redoxresponsive mesoporous silica as carriers for controlled drug delivery: a comparative study based on silica and PEG gatekeepers. Eur. J. Pharm. Sci. 2015, 72, 12-20.
42. Cheng YJ, Luo GF, Zhu JY, Xu XD, Zeng X, Cheng DB, Li YM, Wu Y, Zhang XZ, Zhuo RX, He F. Enzyme-induced and tumor targeted drug delivery system based on multifunctional mesoporous silica nanoparticles. ACS Appl. Mater Interfaces ACS applied materials & interfaces. 2015, 7, 9078-9087.
43. Gan Q, Lu X, Yuan Y, Quian J, Zhou H, Lu X, Shi J, Liu C. A magnetic, reversible pH-responsive nanogated ensemble based on Fe3O4 nanoparticles-capped mesoporous silica. Biomaterials. 2011, 32, 1932-1942.
44. Baeza A, Guisasola E, Ruiz-Hernández E, Vallet-Regí M. Magnetically triggered multidrug release by hybrid mesoporous silica nanoparticles. Chem. Mater. 2012, 24, 517-524.
45. Zhang L, Li Y, Jin Z, Yu JC, Chan KM. An NIR-Triggered and thermally responsive drug delivery platform through DNA/copper sulfide gates. Nanoscale. 2015, 7, 12614-12624.
46. Saito G, Swanson JA, Lee KD. Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv. Drug Deliv. Rev. 2003, 55, 199-215.
47. Wu G, Fang Y-Z, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J. Nutr. 2004, 134, 489-492.
48. Meng F, Hennink WE, Zhong Z. Reduction-sensitive polymers and bioconjugates for biomedical applications. Biomaterials. 2009, 30, 2180-2198.
49. Deng R, Yue Y, Jin F, Chen Y, Kung H-F, Lin MCM, Wu C. Revisit the complexation of PEI and DNA - How to make low cytotoxic and highly efficient PEI gene transfection non-viral vectors with a controllable chain length and structure?. J. Control Release. 2009, 140, 40-46.
50. Luo Z, Cai K, Hu Y, Li J, Ding X, Zhang B, Xu D, Yang W, Liu P. Redox-responsive molecular nanoreservoirs for controlled intracellular anticancer drug delivery based on magnetic nanoparticles. Adv. Mater. 2012, 24, 431-435.
51. Wang H, Liu Y, Li M, Huang H, Xu HM, Hong RJ, Shen H. Multifunctional TiO2 nanowires-modified nanoparticles bilayer film for 3D dye-sensitized solar cells. Optoelectron. Adv. Mater. Rapid Commun. 2010, 4, 1166-1169.
52. Li Z-Y, Hu J-J, Xu Q, Chen S, Jia H-Z, Sun Y-X, Zhuo R-X, Zhang X-Z. A redox-responsive drug delivery system based on RGD containing peptide-capped mesoporous silica nanoparticles. J. Mater. Chem. B. 2015, 3, 39-44.
53. Sun L, Liu Y-J, Yang Z-Z, Qi X-R. Tumor specific delivery with redox-Triggered mesoporous silica nanoparticles inducing neovascularization suppression and vascular normalization. RSC Adv. 2015, 5, 55566-55578.
54. van Rijt SH, Bölükbas DA, Argyo C, Datz S, Lindner M, Oliver Eickelberg O, Königshoffet M, Bein T, Meiners S. Protease-mediated release of chemotherapeutics from mesoporous silica nanoparticles to ex vivo human and mouse lung tumors. ACS Nano. 2015, (Xx).
55. Xu J, Gao F, Li L, Ma HL, Fan Y-S, Liu W, Guo S-S, Zhao X-Z, Wang H. Gelatin-mesoporous silica nanoparticles as matrix metalloproteinases-degradable drug delivery systems in vivo. Microporous Mesoporous Mater. 2013, 182, 165-172.
56. Edwards JV, Prevost N, French A, Concha M, Delucca A, Wu Q. Nanocellulose-based biosensors: design, preparation, and activity of peptide-linked cotton cellulose nanocrystals having fluorimetric and colorimetric elastase detection sensitivity. Engineering. 2013, 2013(September), 20-28.
57. de la Rica R, Aili D, Stevens MM. Enzyme-responsive nanoparticles for drug release and diagnostics. Adv. Drug Deliv. Rev. 2012, 64, 967-978.
58. Vatansever F, de Melo WCMA, Avci P, Vecchio D, Sadasivam M, Gupta A, Chandran R, Karimi M, Parizotto NA, Yin R, Tegos GP, Hamblin MR. Antimicrobial strategies centered around reactive oxygen species-bactericidal antibiotics, photodynamic therapy, and beyond. FEMS Microbiol. Rev. 2013, 37, 955-989.
59. Li J, Liu F, Shao Q, Min Y, Costa M, YeowEKL, Xing B. Enzymeresponsive cell-penetrating peptide conjugated mesoporous silica quantum dot nanocarriers for controlled release of nucleus-Targeted drug molecules and real-Time intracellular fluorescence imaging of tumor cells. Adv. Healthc. Mater. 2014, 3, 1230-1239.
60. Mondragón L, Mas N, Ferragud V, de la Torre C, Agostini A, Martínez-Mánez R, Sancenón F, Amorós P, Pérez-Payá E, Orzáez M. Enzyme-responsive intracellular-controlled release using silica mesoporous nanoparticles capped with e-poly-l-lysine. Chem. - A Eur. J. 2014, 1-12. doi:10.1002/ chem.201400148.
61. Zhu Y, Shi J. A mesoporous core-shell structure for pH-controlled storage and release of water-soluble drug. Microporous Mesoporous Mater. 2007, 103, 243-249.
62. Sun Y, Sun YL, Wang L, Ma J, Yang YW, Gao H. Nanoassembles constructed from mesoporous silica nanoparticles and surfacecoated multilayer polyelectrolytes for controlled drug delivery. Microporous Mesoporous Mater. 2014, 185, 245-253.
63. Yang Y-W. Towards biocompatible nanovalves based on mesoporous silica nanoparticles. MedChemComm. 2011, 2, 1033.
64. Zhang L, Li Y, Yu JC. Chemical modification of inorganic nanostructures for targeted and controlled drug delivery in cancer treatment. J. Mater. Chem. B. 2014, 2, 452.
65. Li H, Tan L-L, Jia P, Li Q-L, Sun Y-L, Zhang J, Ning Y-Q, Yu J, Yang Y-W. Near-infrared light-responsive supramolecular nanovalve based on mesoporous silica-coated gold nanorods. Chem. Sci. 2014, 5, 2804.
66. Chen L, Wang W, Su B, Wen Y, Li C, Zhou Y, Li M, Shi X, Du H, Song Y, Jiang L. A light-responsive release platform by controlling the wetting behavior of hydrophobic surface. ACS Nano. 2014, 8, 744-751.
67. Liu J, Wang C, Wang X, Wang X, Cheng L, Li Y, Liu Z. Mesoporous silica coated single-walled carbon nanotubes as a multifunctional light-responsive platform for cancer combination therapy. Adv. Funct. Mater. 2015, 25, 384-392.
68. He D, Li X, He X, Wang K, Tang J, Yang X, He X, Yang X, Zou Z. Noncovalent assembly of reduced graphene oxide and alkyl-grafted mesoporous silica: an effective drug carrier for near-infrared light-responsive controlled drug release. J. Mater. Chem. B. 2015, 3, 5588-5594.
69. Tarn D, Ferris DP, Barnes JC, Amobrogio MW, Stoddar JF, Zink JI. A reversible light-operated nanovalve on mesoporous silica nanoparticles. Nanoscale. 2015, 1-10. doi:10.1039/c0xx00000x.
70. Freeman MW, Arrott A, Watson JHL. Magnetism in medicine. J. Appl. Phys. 1960, 31, S404-5.
71. Song N, Yang Y-W. Molecular and supramolecular switches on mesoporous silica nanoparticles. Chem. Soc. Rev. 2015, 44, 3474-3504.
72. Dong L, Peng H, Wang S, Zhang Z, Li J, Ai F, Zhao Q, Luo M, Xiong H, Chen L. Thermally and magnetically dual-responsive mesoporous silica nanospheres: preparation, characterization, and properties for the controlled release of sophoridine. J. Appl. Polym. Sci. 2014, 131, 4-11.
73. Thomas CR, Ferris DP, Lee JH, Choi E, Cho MH, Kim ES, Stoddart JF, Shin J-S, Cheon J, Zink JI. Noninvasive remotecontrolled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles. J Am Chem Soc. 2010, 132, 10623-10625.
74. Lee SF, Zhu XM, Wang YXJ, Xuan SH, You Q, Chan WH, Wong CH, Wang F, Yu JC, Cheng CHK, Leung KCF. Ultrasound, pH, and magnetically responsive crown-ether-coated core/shell nanoparticles as drug encapsulation and release systems. ACS Appl. Mater. Interfaces. 2013, 5, 1566-1574.
75. Alberti S, Soler-Illia GJAA, Azzaroni O. Gated supramolecular chemistry in hybrid mesoporous silica nanoarchitectures: controlled delivery and molecular transport in response to chemical, physical and biological stimuli. Chem. Commun. 2015, 51, 6050-6075.
76. Russell MM, Raboin L, Guardado-Alvarez TM, Zink JI. Trapping and release of cargo molecules from a micro-stamped mesoporous thin film controlled by poly(NIPAAm-co-AAm). J. Sol-Gel Sci. Technol. 2013, 70, 278-285.
77. Chang YT, Liao PY, Sheu HS, Tseng YJ, Cheng FY, Yeh CS. Near-infrared light-responsive intracellular drug and sirna release using au nanoensembles with oligonucleotide-capped silica shell. Adv. Mater. 2012, 24, 3309-3314.
78. de la Torre C, Agostini A, Mondragón L, Orzáez M, Sancenón F, Martínez-Mánez R, Marcos MD, Amorós P, Pérez-Payá E. Temperature-controlled release by changes in the secondary structure of peptides anchored onto mesoporous silica supports. Chem. Commun. 2014, 50, 3184-3186.
79. Cho M, Cho WS, Choi M, Kim SJ, Kim HO, Sheen YY, Jeong J. The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol. Lett. 2009, 189, 177-183.
80. Lee S, Yun HS, Kim SH. The comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosis. Biomaterials. 2011, 32, 9434-9443.
81. Slowing I, Trewyn BG, Lin VS-Y. Effect of surface functionalization of MCM-41-Type mesoporous silica nanoparticles on the endocytosis by human cancer cells. J. Am. Chem. Soc. 2006, 128, 14792-14793.
82. Nguyen TPB, Lee JW, Shim WG, Moon H. Synthesis of functionalized SBA-15 with ordered large pore size and its adsorption properties of BSA. Microporous Mesoporous Mater. 2008, 110, 560-569.
83. Maurer-Jones MA, Lin Y-S, Haynes CL. Functional assessment of metal oxide nanoparticle toxicity in immune cells. ACS Nano. 2010, 4, 3363-3373.
84. Yu T, Malugin A, Ghandehari H. Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. ACS Nano. 2011, 5, 5717-5728.
85. Fu C, Liu T, Li L, Liu H, Chen D, Tang F. The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes. Biomaterials. 2013, 34, 2565-2575.
86. Lee S, Kim MS, Lee D, Kwon TK, Khang D, Yun HS, Kim SH. The comparative immunotoxicity of mesoporous silica nanoparticles and colloidal silica nanoparticles in mice. Int. J. Nanomedicine. 2013, 8, 147-158.